HLI

Houlihan Lokey, Inc. Financials Investment Advice Russell 3000
$138.00Close $122.74 – $195.8752-week range Late-januaryNext report · estimated

Highlights

Strengths

  • Accumulation up-day volume 1.5× down-day volume over 50 sessions

Cautions

  • Not in an uptrend 1 of 8 trend conditions
  • Lagging the market RS 32 · weaker than 68% of stocks over 12 months
  • Far from its high 30% below its 52-week high

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Mar 31, 2026 · filed Oct 30, 2026
Off 12-month high 30%
1wk up 5.1% price change
1mo up 9.2% price change
12-month return down 30% market up 11% · its own down 40%
F-score — — Not assessed
Altman Z — Unknown
P/E — price / earnings
PEG — P/E / EPS growth
P/B — price / book
Earnings yield — EBIT / enterprise value
Cheaper than — of the market · not assessed
Revenue growth up 10% year on year
EPS growth up 1% latest quarter · +19 pts
Sales growth up 5% latest quarter · +20 pts
ROE up 19% return on equity
Free cash margin —
D/E — long-term debt / equity
Net debt / EBITDA —
Interest cover —EBIT / interest

Trade setup

ATR% 3.2% $4.44 a day · 2×ATR $129.12
RS 32 / 99 vs the universe
Trend 1 / 8 trend template
Relative volume 1.0× vs 50-day average
Up/down volume 1.53 50 sessions
Implied move — no scheduled report
Trend template · 1 of 8
  • Price above the 50-day average: passes

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • No material dilution
  • Margins and revenue not shrinking
Last reported Oct 28, 2026
Results reaction Oct 28, 2026+5% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $2.6B +10% on FY2025
$0 $5B FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · $1.5B FY2022 · $2.3B FY2023 · $1.8B FY2024 · $1.9B FY2025 · $2.4B FY2026 · $2.6B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $424.0M +6% on FY2025
$0 $500M FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · $312.8M FY2022 · $438.0M FY2023 · $254.0M FY2024 · $280.0M FY2025 · $400.0M FY2026 · $424.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross
  • Net 16%
0% 50% FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · Gross 34% · Net 21% FY2022 · Gross 35% · Net 19% FY2023 · Gross 31% · Net 14% FY2024 · Gross 30% · Net 15% FY2025 · Gross 32% · Net 17% FY2026 · Net 16%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $2B FY21 FY22 FY23 FY24 FY25 FY26 FY2021 · Cash $846.9M · Long-term debt $55.9M FY2022 · Cash $833.7M FY2023 · Cash $714.4M FY2024 · Cash $721.2M FY2025 · Cash $971.0M FY2026 · Cash $1.2B
  FY2021Mar 31, 2021 FY2022Mar 31, 2022 FY2023Mar 31, 2023 FY2024Mar 31, 2024 FY2025Mar 31, 2025 FY2026Mar 31, 2026
Revenue $1.5B $2.3B $1.8B $1.9B $2.4B $2.6B
Gross margin 34% 35% 31% 30% 32% —
Operating income $408.2M $612.9M $341.7M $373.2M $502.6M $527.0M
Net income $312.8M $438.0M $254.0M $280.0M $400.0M $424.0M
Net margin 21% 19% 14% 15% 17% 16%
Earnings per share $4.55 $6.42 $3.76 $4.11 $5.83 $6.20
Cash $846.9M $833.7M $714.4M $721.2M $971.0M $1.2B
Long-term debt $55.9M — — — — —
Shareholders' equity $1.4B $1.4B $1.6B $1.8B $2.2B $2.3B

Filings

SEC EDGAR
FiledReportPeriod to Lag
Oct 30, 2026 Quarterly ↗ Sep 30, 2026 30d
Jul 31, 2026 Quarterly ↗ Jun 30, 2026 31d
May 22, 2026 Annual ↗ Mar 31, 2026 52d
Feb 3, 2026 Quarterly ↗ Dec 31, 2025 34d
Nov 4, 2025 Quarterly ↗ Sep 30, 2025 35d
Aug 5, 2025 Quarterly ↗ Jun 30, 2025 36d
May 15, 2025 Annual ↗ Mar 31, 2025 45d
Feb 4, 2025 Quarterly ↗ Dec 31, 2024 35d
Nov 5, 2024 Quarterly ↗ Sep 30, 2024 36d
Aug 6, 2024 Quarterly ↗ Jun 30, 2024 37d
May 21, 2024 Annual ↗ Mar 31, 2024 51d
Feb 8, 2024 Quarterly ↗ Dec 31, 2023 39d

Current reports